Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-23 4:36 pm Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 1,111 0.240% |
-9,111 (-89.13%) |
Filing History |
| 2022-02-09 11:08 am Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Parian Global Management LP | 0 0.000% |
-13,330 (Position Closed) |
Filing History |
| 2022-02-04 3:19 pm Sale |
2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Hudson Bay Capital Management LP | 0 0.000% |
-10,222 (Position Closed) |
Filing History |
| 2021-03-01 4:38 pm Purchase |
2021-02-22 | 13G | Artelo Biosciences, Inc. ARTL |
Parian Global Management LP | 13,330 7.640% |
13,330 (New Position) |
Filing History |
| 2021-02-16 09:53 am Sale |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
CVI Investments, Inc. | 8,819 4.900% |
-1,404 (-13.73%) |
Filing History |
| 2021-02-10 4:12 pm Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
BIGGER CAPITAL FUND L P | 10,000 4.990% |
0 (Unchanged) |
Filing History |
| 2021-02-08 5:07 pm Purchase |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Hudson Bay Capital Management LP | 10,222 5.740% |
10,222 (New Position) |
Filing History |
| 2021-02-05 4:23 pm Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
KINGSBROOK PARTNERS LP | 8,889 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-15 11:30 am Sale |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Alpha Capital Anstalt | 8,711 4.990% |
-178 (-2.00%) |
Filing History |
| 2021-01-13 09:02 am Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 10,222 4.990% |
0 (Unchanged) |
Filing History |
| 2020-10-26 06:09 am Unchanged |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-10-22 1:18 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Alpha Capital Anstalt | 8,889 5.290% |
8,889 (New Position) |
Filing History |
| 2020-10-19 4:33 pm Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
BIGGER CAPITAL FUND L P | 10,000 5.800% |
10,000 (New Position) |
Filing History |
| 2020-10-19 3:25 pm Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
Iroquois Capital Management, LLC | 10,222 6.670% |
10,222 (New Position) |
Filing History |
| 2020-10-15 10:54 am Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 10,222 6.670% |
10,222 (New Position) |
Filing History |
| 2020-10-15 10:17 am Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
CVI Investments, Inc. | 10,222 6.700% |
10,222 (New Position) |
Filing History |
| 2020-10-15 08:45 am Purchase |
2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL |
KINGSBROOK PARTNERS LP | 8,889 5.800% |
8,889 (New Position) |
Filing History |